Genesystem Co (XKRX:363250) Marketable Securities : ₩0.0 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Genesystem Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Genesystem Co's Marketable Securities for the quarter that ended in Mar. 2024 was ₩0.0 Mil.

Genesystem Co's annual Marketable Securities declined from Dec. 2021 (₩12,000.0 Mil) to Dec. 2022 (₩9,651.8 Mil) and declined from Dec. 2022 (₩9,651.8 Mil) to Dec. 2023 (₩5,257.9 Mil).

Genesystem Co Marketable Securities Historical Data

The historical data trend for Genesystem Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genesystem Co Marketable Securities Chart

Genesystem Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

1.82

12,000.00

9,651.76

5,257.88

Genesystem Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial											12,610.35	9,519.05	9,055.51	5,257.88	-

Genesystem Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Genesystem Co (XKRX:363250) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Genesystem Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Genesystem Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Genesystem Co (XKRX:363250) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genesystem Co Ltd (XKRX:363250) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

200-9, Techno 2-ro, Yuseong-gu, Daejeon, KOR, 34028

Website

http://www.genesystem.co.kr

Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.

Genesystem Co (XKRX:363250) Headlines

No Headlines